Journal
BLOOD
Volume 113, Issue 10, Pages 2363-2369Publisher
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2008-08-172742
Keywords
-
Categories
Funding
- Ministry of Health, Labor, and Welfare
- Scientific Research Expenses for Health, Labor and Welfare Programs
- Foundation for the Promotion of Cancer Research
- Ministry of Education, Culture, Sports, Science, and Technology
- Japanese Government
- Japan Society for the Promotion of Science for Young Scientists
Ask authors/readers for more resources
Vascular endothelial growth factor (VEGF) signaling in endothelial cells serves a critical role in physiologic and pathologic angiogenesis. Endothelial cells secrete soluble VEGF receptor-1 (sVEGFR-1/sFlt-1), an endogenous VEGF inhibitor that sequesters VEGF and blocks its access to VEGF receptors. This raises the question of how VEGF passes through this endogenous VEGF trap to reach its membrane receptors on endothelial cells, a step required for VEGF-driven angiogenesis. Here, we show that matrix metalloproteinase-7 (MMP-7) degrades human sVEGFR-1, which increases VEGF bioavailability around the endothelial cells. Using a tube formation assay, migration assay, and coimmunoprecipitation assay with human umbilical vein endothelial cells (HUVECs), we show that the degradation of sVEGFR-1 by MMP-7 liberates the VEGF(165) isoform from sVEGFR-1. The presence of MMP-7 abrogates the inhibitory effect of sVEGFR-1 on VEGF-induced phosphorylation of VEGF receptor-2 on HUVECs. These data suggest that VEGF escapes the sequestration by endothelial sVEGFR-1 and promotes angiogenesis in the presence of MMP-7. (Blood. 2009; 113: 2363-2369)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available